The US Food and Drug Administration (FDA) has approved suzetrigine 50 mg tablets, a first-in-class nonopioid analgesic for treatment of adults with moderate-to-severe acute pain.

Meta-Analysis Links Metformin to Lower Dementia Risk in T2D

High processed meat consumption increases dementia risk by 13%

As the use of glucagon-like peptide 1 receptor agonists continues to exponentially expand obesity treatment, concerns have arisen regarding their impact on nutrition in people who take them

Women seeking contraception are facing a growing lack of access to services in light of legislative and clinical workforce changes.

Neuroanatomical changes observed in young people who use alcohol or other substances are largely the consequence of exposure to these substances

Colchicine prophylaxis for gout flare in patients initiating urate-lowering therapy is associated with reduced cardiovascular events

Previous research showed that blood pressure variability is linked to poorer thinking skills in white people.

A new evidence-based guideline recommends prescribing metformin when initiating antipsychotic treatment to help mitigate weight gain in certain instances.